News
04-08-2014, 06:20 AM
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the nCounter® PanCancer Pathways Panel, a highly-multiplexed, digital gene expression assay that offers a unique way for translational researchers to investigate cancer biology across all major cancer pathways.
More... (http://www.news-medical.net/news/20140408/Nanostring-Technologies-launches-nCounter-PanCancer-Pathways-Panel.aspx)
More... (http://www.news-medical.net/news/20140408/Nanostring-Technologies-launches-nCounter-PanCancer-Pathways-Panel.aspx)